DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Evaluation of 3-V Bioscience-2640 to reduce de novo lipogenesis in subjects with characteristics of metabolic syndrome.
Accessed June 15, 2021 at:
https://ClinicalTrials.gov/show/NCT02948569
We do not assume any responsibility for the contents of the web pages of other providers.